Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$400M |
| 2 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
+$263M |
| 3 |
JPMorgan Chase
JPM
|
+$197M |
| 4 |
Chevron
CVX
|
+$182M |
| 5 |
ConocoPhillips
COP
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cisco
CSCO
|
+$366M |
| 2 |
Johnson & Johnson
JNJ
|
+$331M |
| 3 |
IBM
IBM
|
+$284M |
| 4 |
Procter & Gamble
PG
|
+$239M |
| 5 |
PepsiCo
PEP
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.53% |
| 2 | Healthcare | 19.45% |
| 3 | Consumer Staples | 17.77% |
| 4 | Energy | 8.18% |
| 5 | Consumer Discretionary | 6.41% |
Similar funds
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q2 2014 Portfolio in Review
As of Q2 2014, Grantham, Mayo, Van Otterloo & Co (GMO) held 603 positions worth $36.8B, down 4% from $38.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Grantham, Mayo, Van Otterloo & Co (GMO) withdrew a net $2.66B in Q2 2014, closing 116 positions and reducing 276 holdings. Its most notable exit was Vanguard FTSE Emerging Markets ETF, an estimated $76M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in SAFEWAY INC worth $37.3M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q2 2014 buy was SAFEWAY INC: 1,085,800 shares worth $37.3M.
- Grantham, Mayo, Van Otterloo & Co (GMO) added most to Express Scripts Holding Company in Q2 2014, an estimated $400M increase.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q2 2014 reduction was Cisco, cutting an estimated $366M.
- Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Vanguard FTSE Emerging Markets ETF in Q2 2014, selling an estimated $76M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 40% of its $36.8B portfolio in Q2 2014.
- Grantham, Mayo, Van Otterloo & Co (GMO) opened 45 new positions and closed 116 in Q2 2014.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value fell 4% quarter-over-quarter to $36.8B.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2014, filed 13 Aug 2014.